Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03122483

Enrollment

250

Registered

2017-04-20

Start date

2016-01-31

Completion date

2017-07-14

Last updated

2017-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Interventions

DIAGNOSTIC_TESTblood biomarker

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Written Informed Consent * Male * 18-70 years old * Presentation with symptoms suggestive of obstructive sleep apnea * Diagnostic sleep study * Blood draw

Exclusion criteria

* Prior (within past year) or current therapy for sleep apnea * Use of opioid pain medication, steroids or allopurinol (within past 30 days) * Use of chronic anti-inflammatory drugs (within past 7 days) * Active cancer under current treatment or monitoring

Design outcomes

Primary

Measure	Time frame	Description
Identification of OSA in high-risk individuals	1 day	Identification of OSA in high-risk individuals

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026